Grove Ventures

Quantum Source is a developer of advanced photonic quantum computing systems based in Rehovot, Israel. The company focuses on creating a scalable quantum architecture that can support millions of qubits, utilizing chip-based photon-atom gates for efficient communication between photonic and atomic qubits. This innovative approach aims to significantly reduce the complexity, footprint, power consumption, and costs associated with quantum computing. By providing versatile building blocks for large-scale quantum systems, Quantum Source is positioned to enable industries to tackle complex problems in areas such as drug and material development, finance, cybersecurity, medicine, and climate simulations. The company's efforts are geared towards making practical, fault-tolerant quantum computers a reality, potentially transforming various sectors.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

NoTraffic Ltd. is a technology company based in Tel Aviv, Israel, founded in 2016, specializing in a traffic management platform that transforms traditional signalized intersections into smart, interconnected systems. The platform facilitates communication between road users and infrastructure through vehicle-to-infrastructure (V2I) technology, optimizing traffic signal timing to enhance traffic flow, prioritize vehicles, and minimize congestion and accidents. By employing advanced artificial intelligence sensors that integrate machine vision and radar, NoTraffic enables real-time detection and classification of various road users, including buses, cyclists, and pedestrians. With operations spanning over 40 states and strategic partnerships with leading distributors, NoTraffic aims to revolutionize mobility and improve road safety, earning recognition as one of the TIME 100 Most Influential Companies for its significant impact on transportation systems.

Deepchecks Ltd is a company based in Tel Aviv-Yafo, Israel, that specializes in developing a machine learning monitoring platform. The platform enables the supervision of the performance and stability of artificial intelligence systems by collecting and analyzing data from various sources in its raw format. Deepchecks provides an open-source testing framework that adheres to best practices, allowing developers to release high-quality large language model applications efficiently without sacrificing the integrity of their testing processes. This focus on monitoring and evaluation helps ensure visibility into data transformations and the overall machine learning pipeline.

Quantum Source is a developer of advanced photonic quantum computing systems based in Rehovot, Israel. The company focuses on creating a scalable quantum architecture that can support millions of qubits, utilizing chip-based photon-atom gates for efficient communication between photonic and atomic qubits. This innovative approach aims to significantly reduce the complexity, footprint, power consumption, and costs associated with quantum computing. By providing versatile building blocks for large-scale quantum systems, Quantum Source is positioned to enable industries to tackle complex problems in areas such as drug and material development, finance, cybersecurity, medicine, and climate simulations. The company's efforts are geared towards making practical, fault-tolerant quantum computers a reality, potentially transforming various sectors.

Quantum Source is a developer of advanced photonic quantum computing systems based in Rehovot, Israel. The company focuses on creating a scalable quantum architecture that can support millions of qubits, utilizing chip-based photon-atom gates for efficient communication between photonic and atomic qubits. This innovative approach aims to significantly reduce the complexity, footprint, power consumption, and costs associated with quantum computing. By providing versatile building blocks for large-scale quantum systems, Quantum Source is positioned to enable industries to tackle complex problems in areas such as drug and material development, finance, cybersecurity, medicine, and climate simulations. The company's efforts are geared towards making practical, fault-tolerant quantum computers a reality, potentially transforming various sectors.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

Lumigo Ltd. is a technology company that focuses on developing a serverless intelligence platform designed to assist developers in monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and headquartered in Tel Aviv, Israel, Lumigo's platform leverages data analysis to learn the normal behavior of serverless applications, providing live visual maps and insights that help identify and resolve issues quickly. The platform offers end-to-end visibility and traceability, allowing operations teams to understand each request and pinpoint the root causes of problems, including interactions with adjacent services like databases and storage. By enabling actionable alerts based on user behavior analytics, Lumigo empowers organizations to prevent service disruptions and enhance the reliability of their cloud applications.

NeuroBlade, LTD. is a technology company that specializes in developing artificial intelligence (AI) chips focused on the inference stage for data centers and end devices. Founded in 2017 and headquartered in Hod-Hasharon, Israel, the company aims to address memory bottlenecks and enhance analytical query performance. NeuroBlade's innovative solutions leverage proprietary computational memory technology and extensive expertise in hardware, software, and algorithms, positioning the company at the forefront of analytics acceleration for large data sets. With operations extending to Taipei, Taiwan, and Palo Alto, California, NeuroBlade is dedicated to transforming infrastructure for data analytics while reducing costs and power consumption for businesses, ultimately facilitating faster insights.

NoTraffic Ltd. is a technology company based in Tel Aviv, Israel, founded in 2016, specializing in a traffic management platform that transforms traditional signalized intersections into smart, interconnected systems. The platform facilitates communication between road users and infrastructure through vehicle-to-infrastructure (V2I) technology, optimizing traffic signal timing to enhance traffic flow, prioritize vehicles, and minimize congestion and accidents. By employing advanced artificial intelligence sensors that integrate machine vision and radar, NoTraffic enables real-time detection and classification of various road users, including buses, cyclists, and pedestrians. With operations spanning over 40 states and strategic partnerships with leading distributors, NoTraffic aims to revolutionize mobility and improve road safety, earning recognition as one of the TIME 100 Most Influential Companies for its significant impact on transportation systems.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Teramount Ltd. is a Jerusalem-based company founded in 2013 that specializes in manufacturing and selling innovative optical connectivity products. Its flagship offering, the patent-pending Photonic-Plug, provides a novel solution for connecting optics to silicon, facilitating advancements in silicon photonics. This technology allows semiconductor manufacturers to integrate optical components into their processes while utilizing traditional semiconductor fabrication methods. The Photonic-Plug enhances assembly tolerances, enabling passive alignment and efficient volume packaging on standard CMOS assembly lines. By improving throughput and reducing costs, Teramount's products support the deployment of transceivers and co-packaged switch connectivity in data centers and telecommunications applications, thereby enabling fabless semiconductor companies to expand into silicon photonics.

BeyondMinds Ltd. is a technology company specializing in the development of artificial intelligence (AI)-based software aimed at facilitating enterprise product deployments. Founded in 2018 and headquartered in Tel Aviv-Yafo, Israel, with additional offices in New York and London, BeyondMinds has created a production-centric AI platform designed to address the challenges of real-world application of AI solutions. The company's Modular Engine supports various business sectors, including finance, industry, and government, by providing customized, production-ready AI systems. This approach aims to reduce the high failure rates associated with AI adoption, enabling organizations to implement sustainable and ROI-positive transformations effectively.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

NeuroBlade, LTD. is a technology company that specializes in developing artificial intelligence (AI) chips focused on the inference stage for data centers and end devices. Founded in 2017 and headquartered in Hod-Hasharon, Israel, the company aims to address memory bottlenecks and enhance analytical query performance. NeuroBlade's innovative solutions leverage proprietary computational memory technology and extensive expertise in hardware, software, and algorithms, positioning the company at the forefront of analytics acceleration for large data sets. With operations extending to Taipei, Taiwan, and Palo Alto, California, NeuroBlade is dedicated to transforming infrastructure for data analytics while reducing costs and power consumption for businesses, ultimately facilitating faster insights.

Rapid Software Solutions Ltd. is a technology company based in Haifa, Israel, specializing in software applications and Software-as-a-Service solutions. The firm is known for its RapidAPI Hub, which is the largest API hub globally, allowing over 4 million developers to discover, evaluate, and integrate more than 40,000 APIs from prominent providers. Rapid also offers a comprehensive development platform called RapidAPI Studio, enabling developers to design, develop, test, monitor, and publish their APIs seamlessly. For enterprise clients, the company provides RapidAPI Enterprise Hub, a customizable platform that facilitates the management and connection of both internal and external APIs. Founded in 2014 and headquartered in San Francisco, Rapid aims to support modern developers by streamlining access to essential API resources.

Lumigo Ltd. is a technology company that focuses on developing a serverless intelligence platform designed to assist developers in monitoring, troubleshooting, and optimizing serverless applications. Founded in 2018 and headquartered in Tel Aviv, Israel, Lumigo's platform leverages data analysis to learn the normal behavior of serverless applications, providing live visual maps and insights that help identify and resolve issues quickly. The platform offers end-to-end visibility and traceability, allowing operations teams to understand each request and pinpoint the root causes of problems, including interactions with adjacent services like databases and storage. By enabling actionable alerts based on user behavior analytics, Lumigo empowers organizations to prevent service disruptions and enhance the reliability of their cloud applications.

Nucleai Ltd. is a spatial biology company based in Tel Aviv-Yafo, Israel, founded in 2017. It has developed an AI-powered pathology platform that enhances drug development and improves patient outcomes by analyzing tissue datasets to provide insights into cancer biology. The platform is designed to detect various diseases, including cancer, prostate, breast, and gastrointestinal conditions, through advanced machine learning and computer vision techniques. By improving the interpretation of biopsies and supporting treatment decisions, Nucleai aims to increase the efficacy of clinical trials and enhance patient care. The company collaborates with leading pharmaceutical firms, licensing its technology for internal research and participating in biomarker discovery projects. Nucleai serves hospitals and laboratories primarily in the United States and Israel.

NeuroBlade, LTD. is a technology company that specializes in developing artificial intelligence (AI) chips focused on the inference stage for data centers and end devices. Founded in 2017 and headquartered in Hod-Hasharon, Israel, the company aims to address memory bottlenecks and enhance analytical query performance. NeuroBlade's innovative solutions leverage proprietary computational memory technology and extensive expertise in hardware, software, and algorithms, positioning the company at the forefront of analytics acceleration for large data sets. With operations extending to Taipei, Taiwan, and Palo Alto, California, NeuroBlade is dedicated to transforming infrastructure for data analytics while reducing costs and power consumption for businesses, ultimately facilitating faster insights.